Profile | GDS4284 / 226649_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 697.4 | 69 |
GSM687648 | Patient 402 control | 724.843 | 69 |
GSM687653 | Patient 403 control | 455.665 | 63 |
GSM687658 | Patient 404 control | 444.441 | 62 |
GSM687663 | Patient 411 control | 643.213 | 67 |
GSM687668 | Patient 422 control | 244.222 | 52 |
GSM687673 | Patient 424 control | 454.806 | 61 |
GSM687678 | Patient 425 control | 172.258 | 44 |
GSM687683 | Patient 427 control | 428.912 | 60 |
GSM687688 | Patient 428 control | 314.221 | 56 |
GSM687695 | Patient 441 control | 279.906 | 47 |
GSM687699 | Patient 443 control | 531.274 | 64 |
GSM687704 | Patient 444 control | 1460.26 | 80 |
GSM687707 | Patient 448 control | 602.114 | 66 |
GSM687712 | Patient 449 control | 1109.62 | 76 |
GSM687719 | Patient 450 control | 640.847 | 66 |
GSM687724 | Patient 451 control | 385.698 | 59 |
GSM687728 | Patient 452 control | 824.932 | 72 |
GSM687646 | Patient 401 treated 24h | 719.921 | 68 |
GSM687649 | Patient 402 treated 24h | 919.767 | 72 |
GSM687665 | Patient 411 treated 24h | 481.263 | 62 |
GSM687651 | Patient 402 treated 4 weeks | 660.353 | 67 |
GSM687667 | Patient 411 treated 4 weeks | 801.881 | 70 |
GSM687670 | Patient 422 treated 24h | 285.065 | 54 |
GSM687671 | Patient 422 treated 4 weeks | 405.946 | 60 |
GSM687654 | Patient 403 treated 24h | 316.821 | 58 |
GSM687675 | Patient 424 treated 24h | 647.338 | 67 |
GSM687685 | Patient 427 treated 24h | 372.197 | 59 |
GSM687656 | Patient 403 treated 4 weeks | 338.694 | 59 |
GSM687677 | Patient 424 treated 4 weeks | 677.615 | 68 |
GSM687687 | Patient 427 treated 4 weeks | 477.729 | 63 |
GSM687692 | Patient 428 treated 4h | 598.218 | 66 |
GSM687716 | Patient 449 treated 4h | 1117.22 | 76 |
GSM687722 | Patient 450 treated 4h | 728.378 | 69 |
GSM687680 | Patient 425 treated 24h | 243.16 | 52 |
GSM687690 | Patient 428 treated 24h | 524.006 | 65 |
GSM687700 | Patient 443 treated 24h | 189.198 | 39 |
GSM687705 | Patient 444 treated 24h | 1011.3 | 74 |
GSM687714 | Patient 449 treated 24h | 1069.73 | 75 |
GSM687721 | Patient 450 treated 24h | 581.925 | 65 |
GSM687682 | Patient 425 treated 4 weeks | 167.528 | 46 |
GSM687694 | Patient 428 treated 4 weeks | 377.974 | 60 |
GSM687702 | Patient 443 treated 4 weeks | 550.761 | 64 |
GSM687718 | Patient 449 treated 4 weeks | 1331.09 | 79 |
GSM687723 | Patient 450 treated 4 weeks | 730.177 | 69 |
GSM687661 | Patient 404 treated 4h | 330.46 | 56 |
GSM687710 | Patient 448 treated 4h | 500.824 | 64 |
GSM687726 | Patient 451 treated 4h | 365.641 | 58 |
GSM687730 | Patient 452 treated 4h | 1475.71 | 81 |
GSM687660 | Patient 404 treated 24h | 185.837 | 42 |
GSM687697 | Patient 441 treated 24h | 174.468 | 39 |
GSM687709 | Patient 448 treated 24h | 597.631 | 66 |
GSM687725 | Patient 451 treated 24h | 344.008 | 56 |
GSM687729 | Patient 452 treated 24h | 352.545 | 56 |
GSM687727 | Patient 451 treated 4 weeks | 241.608 | 49 |
GSM687731 | Patient 452 treated 4 weeks | 552.995 | 65 |